The Wrong Investor Can Change the Company You Build

Why pre-seed and seed founders need to look beyond the term sheet when choosing capital.

For deep-tech founders, understanding the capital movements we explored in our last post is important. But once you know which investors are interested in your technology, often a more personal question emerges: Whose capital will help you build the business you actually want?

A term sheet can change the outlook for an early-stage company almost overnight. It may provide the runway to hire critical talent, reach the next technical milestone, or begin commercial work that has been waiting for funding.

Naturally, founders focus on valuation, dilution, and the size of the check. But at pre-seed and seed stage, the company’s strongest commercial pathway may not yet be clear. Sometimes customer discovery may reveal a better market. And often qualification takes longer than anticipated. And over time strategic partners may help founders identify an application not considered previously.

Given all the shifts that likely occur as the technical and commercial path starts to solidify, an investor who supports today’s plan needs to bring the flexibility to also become someone the founder can continue to work with when new evidence changes original plans.

Unfortunately, not all capital supports the same future.

The First Check is only Part of the Relationship

Private capital is staying invested longer, making it increasingly important for founders to understand whether prospective investors can grow with them. McKinsey’s Global Private Markets Report 2026 found that the average holding period for private-equity buyout investments had reached 6.6 years, with more than 16,000 companies held for over four years. Even among mature businesses, investors are finding that realizing returns can take longer than anticipated.

For deep-tech founders, long development timelines are already part of the journey. A promising material may need years of customer qualification. An aerospace technology may require extensive testing before deployment. An energy startup may prove an important engineering principle long before it can deliver a commercial product.

The challenge is not simply finding an investor willing to fund the next milestone. It is finding one whose expectations, resources, and investment timeline can accommodate the journey beyond it.

A seed-stage investor may be enthusiastic about the technology today but face pressure to realize returns before the company reaches its strongest commercial opportunity. Others may have the patience but lack the capacity to participate in future rounds. Understanding that difference early can influence which markets a founder pursues, how aggressively the company scales, and how much freedom it retains when commercial evidence points in a new direction.

OneWeb's experience illustrates the importance of the second question. The satellite broadband company had made substantial technical progress when its largest investor, SoftBank, declined to provide further financing. OneWeb entered bankruptcy protection in 2020 before receiving new backing from the UK government and Bharti Global.

An investor's belief in the technology does not necessarily mean they have the capacity or willingness to finance its entire development journey.

At seed stage, founders should understand what their investors can realistically support after the first round, how they think about follow-on funding, and what milestones they expect the company to reach before committing more.

Different Investors May See Different Companies

A venture fund, corporate investor, family office, and government-backed fund may all be interested in the same technology. Their reasons for investing can be very different.

A venture fund may be looking for a business capable of producing a substantial exit. A corporate investor may see a future supplier, access to intellectual property, or a technology that strengthens its existing operations. A family office may be interested in building a long-term industrial asset. Patient-capital programs may support technologies with strategic importance or development timelines that conventional investors find difficult to accommodate.

Each can bring genuine value. Problems emerge when founders assume that shared enthusiasm for the technology means shared expectations for the business.

That tension is hardly new. Friendster attracted major venture backing as its social network grew rapidly in the early 2000s, but its infrastructure struggled under demand. Founder Jonathan Abrams later described how a large investor board and poorly integrated initiatives distracted the company from fixing its core engineering problems.

For an early-stage deep-tech company, the equivalent disagreement might be whether to complete another technical development cycle, pursue a demanding but valuable customer qualification process, or launch a narrower application to generate revenue sooner.

The founder and investor may both want the company to succeed. They may disagree about what success requires next.

Strategic Capital Can Open Doors and Narrow Them

Corporate investors can offer something especially valuable to deep-tech startups: access to engineering expertise, manufacturing infrastructure, distribution, and potential customers.

Commonwealth Fusion Systems illustrates what aligned strategic relationships can make possible. Google, an investor since 2021, increased its investment in 2025 and agreed to purchase 200 megawatts of electricity from the company’s planned commercial fusion plant. Eni, a shareholder since 2018, expanded its technical collaboration with an agreement to purchase more than $1 billion in future power. Commercial fusion remains to be proven at scale, but these commitments connect financing with prospective demand.

In September 2026, a $1.9 billion U.S. government loan to restart Iowa’s Duane Arnold nuclear plant followed Google’s 25-year power purchase agreement for the facility. Google also reached a separate agreement with Georgia Power to support upgrades to existing reactors. Together, these deals show Google pursuing multiple routes to reliable electricity rather than waiting for any single technology to mature.

For Commonwealth Fusion Systems, the ambition is to establish a commercial market for fusion energy. For Google, it is to secure reliable power. Those objectives can reinforce each other, but founders need to understand where a strategic partner’s priorities align with their own and where they may eventually diverge.

Equally important is understanding which part of the company a strategic investor values most. When Google acquired Motorola Mobility, its patent portfolio was a significant part of the rationale. Google later sold the handset business to Lenovo while retaining most of those patents. The transaction illustrates how a strategic owner may value a company’s intellectual property differently from the standalone business built around it.

For a seed-stage founder, these distinctions matter. An industrial investor may be interested in one application while the technology has potential across several markets. A commercial partnership may create immediate momentum but introduce exclusivity that limits future customers.

Strategic capital can help create your market. The important question is whether it also preserves your freedom to build the broader business you envision.

Motorola's history is much broader than that transaction, but the distinction is useful for founders: a strategic buyer may value the intellectual property differently from the standalone company built around it.

An industrial investor may want one application of a technology while the founder sees opportunities across several markets. A corporate partner may offer immediate commercial access while seeking exclusivity that limits future customers.

Neither outcome is necessarily wrong. What matters is whether the founder understands the trade-off before agreeing to it.

Your First Investors Help Shape Your Options

At pre-seed and seed stage, commercial assumptions are still being tested. That makes the ability to adapt especially valuable.

Imagine an advanced materials startup that accepts funding from a venture firm and a corporate investor. The venture firm expects rapid commercial progress. The corporate investor is interested in applying the material within its own manufacturing operations.

A year later, customer discovery reveals a larger opportunity in a different industry, but pursuing it will require another two years of qualification.

Will both investors support the change? Does the corporate investment restrict work with competitors? Can the company raise capital from another strategic investor? Would the venture firm support a slower route if the long-term opportunity is stronger?

Those questions are easier to discuss before the investment than after the company needs permission, additional funding, or a change in strategy.

Founders do not need investors with identical objectives. A thoughtful mix of financial, strategic, and patient capital can strengthen a company. They do need to understand where those objectives may diverge and how much freedom the investment terms preserve.

Closing Thoughts:

At Agrotera, we see investor selection as part of Commercial De-Risking™. Securing capital for today’s development plan is important, but equally important is building a financing strategy that supports your company as its commercial direction becomes clearer. Before accepting investment, make sure you understand your prospective investor’s growth and exit expectations, follow-on funding capacity, strategic interests, governance rights, and willingness to support a change in market direction. These conversations are much easier while everyone is enthusiastic about the opportunity than when a milestone slips, a new market emerges, or another financing round is needed.

The term sheet tells you what an investor is willing to give you today. Their investment philosophy tells you what they may expect from you five years from now. Choosing the right investor is not about finding someone who will agree with every decision. It is about finding capital partners who understand the business you want to build and can support you as commercial evidence reveals the best way forward.

If you’re evaluating potential investors or considering how an early financing round could shape your commercialization strategy, we’d welcome the opportunity to compare notes.

©Agrotera Group. All rights reserved.